StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report issued on Thursday. The firm issued a buy rating on the stock.
Mannatech Price Performance
MTEX opened at $10.43 on Thursday. The company has a 50 day moving average of $8.55 and a two-hundred day moving average of $7.79. Mannatech has a 52-week low of $6.75 and a 52-week high of $13.00. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The company has a market cap of $19.61 million, a P/E ratio of -12.88 and a beta of 1.18.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The business had revenue of $31.73 million for the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Insider Trades May Not Tell You What You Think
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Why Are Stock Sectors Important to Successful Investing?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
